Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
advisor, agreeable, al, alleging, allele, anal, apparent, appeal, Arthur, attention, AUC, bacterium, baseline, begun, belief, Bertolino, biopsy, body, bowel, building, called, carbapenamase, CDC, circulation, CL, clearance, climate, cm, Cmax, CMO, cohesion, coli, complaint, consoldiated, Copenhagen, CRE, CSO, curve, Cyclic, defending, dermatology, dialogue, dismissed, disruptive, divided, Division, dosage, earliest, endoscopic, enema, evenly, fall, feedback, foam, frequency, greatest, hasten, hepatic, house, hypersensitivity, IBD, Ideally, IGA, incentivize, inflammation, interleukin, iterative, joined, Kepivance, KPC, lawsuit, learned, lessee, lessor, MBA, meaningful, MEC, mg, misleading, moderate, motion, mouth, muted, NYSE, ototoxic, pharmacoeconomic, piggyback, PK, plaintiff, post, predominantly, proven, rationale, relapsed, reputation, retention, RNA, Rosen, screening, serum, shorter, slower, Southern, SPA, statistical, steady, step, Steven, straight, streamlining, sundry, swiftly, threat, unresolved, unvested, urgent, Vd, Venezuela, verge, water, week, window, wrote
Removed:
ACF, American, annually, antagonist, antitumor, apoptotic, array, assured, cancelled, cellular, charitable, charity, chemotherapeutic, chosen, coarse, complement, computational, computer, converted, cooperate, counter, directed, dollar, donation, enhance, escalating, family, feature, folate, grain, HDAC, hundred, induction, led, liquidated, Lymphoma, modulating, mutant, mutation, mutually, myeloma, obligated, Penn, piggy, preferred, principle, promote, reactivation, recently, repurchase, sensitivity, strongly, subcutaneously, supplying, synergistic, thereto, toxicity, tranche, transcription, vitro, wild
Filing tables
Filing exhibits
IPIX similar filings
Filing view
External links
EXHIBIT 32.2
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of Cellceutix Corporation, a Nevada corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
| · | The Annual Report on Form 10-K for the fiscal year ended June 30, 2016 of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
|
| · | the information contained in the Annual Report on Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated: September 12, 2016 | By: | /s/ Leo Ehrlich | |
Leo Ehrlich, |